Myrbetriq and Rytary drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Myrbetriq (mirabegron) and Rytary (carbidopa; levodopa). Common drug interactions include immobile among females and fall among males.
The phase IV clinical study analyzes what interactions people have when they take Myrbetriq and Rytary. It is created by eHealthMe based on reports of 554 people who take the same drugs from the FDA, and is updated regularly.
What is Myrbetriq?
Myrbetriq has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 33,658 Myrbetriq users. Check the latest studies of Myrbetriq.
What is Rytary?
Rytary has active ingredients of carbidopa; levodopa. eHealthMe is studying from 17,270 Rytary users. Check the latest studies of Rytary.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
554 people who take Myrbetriq and Rytary together, and have interactions are studied.
What are the common drug interactions of Myrbetriq and Rytary, by gender? *
What are the common drug interactions of Myrbetriq and Rytary, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Myrbetriq and Rytary?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Myrbetriq and Rytary:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Myrbetriq:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Rytary:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Myrbetriq and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rytary and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on mirabegron and carbidopa; levodopa (the active ingredients of Myrbetriq and Rytary, respectively), and Myrbetriq and Rytary (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Inspra and Diarrhoea for Men aged 60+ - a second ago
- Inspra and Stools - Watery for Men aged 60+ - a second ago
- Inspra and Loose Bowel Movements for Men aged 60+ - a second ago
- Inspra and Frequent Bowel Movements for Men aged 60+ - 2 seconds ago
- Inspra and Diarrhea for Men aged 60+ - 2 seconds ago
- Drug interactions of Septra and Cellcept - 9 seconds ago
- Gingival Bleeding and drugs of ingredients of mycophenolate mofetil - 9 seconds ago
- Lutein and Vasovagal for Women aged 60+ - 23 seconds ago
- Lutein and Syncope for Women aged 60+ - 23 seconds ago
- Lutein and Passed Out for Women aged 60+ - 24 seconds ago